MBF Therapeutics Inc. logo

MBF Therapeutics Inc.

Next Generation Immunotherapeutics for Life Sciences

8 employees · est. 2008

VS
Valneva logo

Valneva

Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya

637 employees · est. 2013 · Saint-herblain, France

MBF Therapeutics Inc. is the older company (2008 vs 2013); Valneva is the larger of the two.

Side-by-Side Comparison

MBF Therapeutics Inc. Valneva
Founded
2008 older 2013
Headquarters
Not tracked yet Saint-herblain, France
Employees
8 637 larger
Industry
Biotechnology, Health and Wellness, Life Sciences Biotechnology, Health Care, Health and Wellness
Funding Stage
Grant Grant
Total Funding
$851.00K $720.10M
Funding Rounds
4 15
Services
Not tracked yet Vaccine Research and Development, Manufacturing of Vaccines, Commercialization of Vaccines, Marketing and Distribution
Target Customers
Not tracked yet Healthcare Providers, Travelers, Health Organizations, Governments, Investors
Taxonomy
Immunotherapeutics, DNA Vaccine, Veterinary Medicine, Animal Health, T-Max Platform, Respiratory Viral Diseases, Porcine Reproductive And Respiratory Syndrome, African Swine Fever, Gene-based Vaccines, Checkpoint Inhibitor Therapies, Canine Oncology, Infectious Diseases, Livestock Vaccines, Clinical-stage Company, Antigen Selection Specialty Vaccines, Infectious Disease Prevention, Prophylactic Vaccines, Vaccine Modalities, First-in-Class Vaccines, Only-in-Class Vaccines, Lyme Disease Vaccine, Chikungunya Vaccine, Travel Vaccines, Vaccine R&D, Vaccine Manufacturing, Clinical Development, Public Health Threats, Pfizer Partnership, Zika Virus Vaccine
Website
mbftherapeutics.com valneva.com
MBF Therapeutics Inc. logo

About MBF Therapeutics Inc.

MBF Therapeutics Inc. is a biotechnology startup that focuses on developing next-generation immunotherapeutics for the life sciences industry. The company's innovative T-Max™ immunotherapeutic DNA vaccine platform is primarily targeted at animal applications, with potential opportunities in human he...

Valneva logo

About Valneva

Valneva, founded in 2013, is a France-based specialty vaccine company renowned for addressing infectious diseases with significant unmet needs. With a forward-thinking approach, the company prides itself on offering first-, best-, or only-in-class vaccine solutions. Their portfolio includes the worl...

We will tell you when either one moves

BounceWatch watches MBF Therapeutics Inc. and Valneva for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at MBF Therapeutics Inc. and Valneva — by email.

Frequently Asked Questions

MBF Therapeutics Inc. — Next Generation Immunotherapeutics for Life Sciences. Valneva — Specialty vaccine company focused on prevention of infectious diseases with major unmet need, such as Lyme & chikungunya. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
MBF Therapeutics Inc. has raised $851.00K while Valneva has raised $720.10M.
MBF Therapeutics Inc. and Valneva operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare MBF Therapeutics Inc. with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at MBF Therapeutics Inc. on 12 Sep 2024, and Valneva on 11 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy